APA   Click to copy
Marinho, A., Batuca, J., Miranda, J., Caixas, U., Dias, C., Branco, T., … Pereira, S. (2021). The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein A1 and for modulating anti-HDL antibodies. Pharmacological Research, 27, 105446. https://doi.org/10.1016/j.phrs.2021.105446

Chicago/Turabian   Click to copy
Marinho, A., J. Batuca, J. Miranda, U. Caixas, C. Dias, T. Branco, K. Soto, et al. “The 2-Hydroxy-Nevirapine Metabolite as a Candidate for Boosting Apolipoprotein A1 and for Modulating Anti-HDL Antibodies.” Pharmacological research 27 (2021): 105446.

MLA   Click to copy
Marinho, A., et al. “The 2-Hydroxy-Nevirapine Metabolite as a Candidate for Boosting Apolipoprotein A1 and for Modulating Anti-HDL Antibodies.” Pharmacological Research, vol. 27, 2021, p. 105446, doi:10.1016/j.phrs.2021.105446.

@article{a2021a,
  title = {The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein A1 and for modulating anti-HDL antibodies.},
  year = {2021},
  journal = {Pharmacological research},
  pages = {105446},
  volume = {27},
  doi = {10.1016/j.phrs.2021.105446},
  author = {Marinho, A. and Batuca, J. and Miranda, J. and Caixas, U. and Dias, C. and Branco, T. and Soto, K. and Pinheiro, P. and Bourbon, M. and Marques, M. M. and Antunes, A. and Monteiro, E. and Pereira, S.}
}